fractionated stereotactic radiotherapy

RADIATION7 trials

Sponsors

AHS Cancer Control Alberta, University of Colorado, Denver, Rigshospitalet, Denmark, Chinese Academy of Medical Sciences, University of Erlangen-Nürnberg Medical School

Conditions

AcromegalyBrain MetastasesBrain Metastases, AdultCerebral Metastases of Solid CancersChemotherapyLung CancerLung NeoplasmsMalignant Gliomas

Phase 1

Dose Escalation Study of Vandetanib With Hypofractionated Stereotactic Radiotherapy in Recurrent Malignant Gliomas

CompletedNCT00822887

University of Colorado, DenverMalignant Gliomas

Start: 2007-03-31End: 2011-01-31Updated: 2013-06-26

Phase 2

Stereotactic Radiotherapy Plus Temozolomide for Refractory Brain Metastases

CompletedNCT02654106

Chinese Academy of Medical SciencesBrain Metastases

Start: 2011-10-31End: 2015-11-30Updated: 2017-06-06

Phase 3

Fractionated Stereotactic Radiotherapy vs. Single Session Radiosurgery in Patients With Larger Brain Metastases

RecruitingNCT03697343

University of Erlangen-Nürnberg Medical SchoolCerebral Metastases of Solid Cancers

Start: 2021-05-18End: 2026-05-31Target: 382Updated: 2022-12-13

Unknown Phase

Phase I/II Study of Fractionated Stereotactic Radiotherapy for Medically Inoperable NSCLC or Metastatic Lung Tumours

CompletedNCT00351962

AHS Cancer Control AlbertaLung Cancer, Lung Neoplasms

Start: 2006-09-30End: 2014-07-02Updated: 2017-09-21

Fractionated Stereotactic Radiotherapy in Patients With Acromegaly

CompletedNCT00934271

Rigshospitalet, DenmarkAcromegaly

Start: 2002-01-31End: 2008-01-31Updated: 2014-10-28

FSRT Combined With TMZ for Large BMs: a PSM Study

CompletedNCT03338075

Chinese Academy of Medical SciencesBrain Metastases, Chemotherapy, Radiotherapy

Start: 2016-01-01End: 2017-08-01Updated: 2017-11-09

Fractionated Stereotactic Radiotherapy for Limited Small Volume Brain Metastases

CompletedNCT07405047

Cancer Institute and Hospital, Chinese Academy of Medical SciencesBrain Metastases, Adult

Start: 2022-09-01End: 2025-09-01Updated: 2026-02-12

Related Papers

A Phase II Trial of Concurrent Temozolomide and Hypofractionated Stereotactic Radiotherapy for Complex Brain Metastases

The Oncologist2019-04-177 citations

Efficacy of hypofractionated stereotactic radiotherapy combined with temozolomide for large brain metastases: a prospective clinical study

Zhonghua fangshe zhongliuxue zazhi2016-04-15